Belite Bio Inc ADR (BLTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31,677 | 88,157 | 42,089 | 17,344 | 25,618 |
| Marketable Securities | 113,472 | N/A | N/A | N/A | N/A |
| Receivables | 575 | 836 | 2 | N/A | N/A |
| TOTAL | $147,073 | $89,940 | $42,807 | $17,431 | $25,668 |
| Non-Current Assets | |||||
| PPE Net | 444 | 490 | 541 | 94 | 46 |
| Intangibles | 31 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 4,584 | 4,212 | 925 | 823 | 27 |
| TOTAL | $5,059 | $4,702 | $1,466 | $917 | $73 |
| Total Assets | $152,132 | $94,642 | $44,273 | $18,348 | $25,741 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13 | 0 | 0 | 71 | 26 |
| Accrued Expenses | 5,761 | 3,325 | 1,906 | 1,564 | 946 |
| TOTAL | $6,050 | $3,633 | $2,104 | $1,635 | $972 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 261 | 578 | 668 | 31,806 | 31,806 |
| TOTAL | $261 | $578 | $668 | $31,806 | $31,806 |
| Total Liabilities | $6,311 | $4,211 | $2,772 | $33,441 | $32,778 |
| Shareholders' Equity | |||||
| Common Shares | 3 | 3 | 3 | 1 | 1 |
| Retained earnings | -107,647 | -71,503 | -39,871 | -27,223 | -17,557 |
| Other shareholders' equity | -660 | -374 | -392 | -196 | -44 |
| TOTAL | $145,821 | $90,431 | $41,501 | $-15,093 | $-7,037 |
| Total Liabilities And Equity | $152,132 | $94,642 | $44,273 | $18,348 | $25,741 |